Novartis Executive and Leadership Team

Sylvester Feddes, the Country President & Chief Executive Officer (Brazil) at Novartis, directs all strategic and operational initiatives within the Brazilian market. This leadership role involves driving the company's mission to develop and produce innovative medications and healthcare solutions tailored to the specific needs of Brazil. Feddes oversees the integration of research and development efforts with commercial operations to ensure effective market penetration and patient access to critical treatments. The scope of this position includes managing cross-functional teams to achieve ambitious growth targets and enhance Novartis's presence in one of South America's largest pharmaceutical markets. Sylvester Feddes ensures alignment with global corporate objectives while adapting strategies to local regulatory and economic landscapes, thereby reinforcing Novartis's commitment to improving patient outcomes across diverse therapeutic areas. This executive's focus is on fostering a culture of scientific excellence and operational efficiency throughout the Brazilian division.

Michael Heo, the Chief Financial Officer, & Distributor Markets (Malaysia, South, Asia) at Novartis, manages all financial operations and strategic fiscal planning for the designated Asian regions. This critical role involves overseeing financial performance, budgeting, forecasting, and resource allocation to support the company's growth objectives in these key markets. Heo's responsibilities extend to managing financial relationships with distributors and ensuring compliance with local financial regulations across Malaysia and other South Asian territories. The position requires a robust understanding of international finance and the pharmaceutical industry's economic dynamics. Michael Heo drives financial efficiency and provides strategic insights to optimize profitability and market share within the distributor networks. This executive's leadership ensures the financial health and sustainability of Novartis's operations in a complex and rapidly evolving economic environment, directly contributing to the company's global mission of developing innovative healthcare solutions.

Irfan Parkar, the Chief Financial Officer, Levant at Novartis, directs financial strategy and operations for the Levant region. This executive role encompasses comprehensive financial planning, budgeting, and analysis to support Novartis's business objectives in this key geographical area. Parkar is responsible for ensuring financial integrity, managing risk, and optimizing resource allocation to drive sustainable growth and profitability. The position requires a deep understanding of financial markets and the pharmaceutical industry within the Levant. Irfan Parkar collaborates with regional leadership to implement financial controls and identify opportunities for operational efficiency. This executive's leadership ensures that financial resources are effectively deployed to advance the development and delivery of innovative medications, reinforcing Novartis's commitment to improving patient lives across the Levant. Parkar's strategic financial management is crucial for navigating the region's economic complexities.

Francisco Martinez, the Chief Financial Officer, Operations at Novartis, oversees the financial management and strategic planning for the company's global operational functions. This executive role is critical in ensuring the efficient allocation of resources and the financial viability of manufacturing, supply chain, and other operational activities. Martinez's responsibilities include developing budgets, managing costs, and implementing financial controls to optimize operational performance across Novartis's worldwide facilities. The position demands extensive expertise in financial accounting, corporate finance, and operational efficiency within the pharmaceutical manufacturing sector. Francisco Martinez provides crucial financial insights that support strategic decision-making, driving cost-effectiveness and ensuring the reliable production of innovative medications. This executive's leadership is fundamental to maintaining Novartis's competitive edge and its ability to deliver life-changing treatments to patients globally.

Waseephol Vuthiparum, the Chief Financial Officer, Country at Novartis, directs financial strategy and operations for a specific country market. This executive role involves comprehensive financial planning, budgeting, and analysis to support the company's growth and mission within that nation. Vuthiparum is responsible for ensuring financial integrity, managing local regulatory compliance, and optimizing resource allocation to drive sustainable business performance. The position requires a strong understanding of local financial regulations and the pharmaceutical industry's economic landscape within the designated country. Waseephol Vuthiparum collaborates with country leadership to implement robust financial controls and identify opportunities for enhanced operational efficiency. This executive's leadership ensures that financial resources are effectively managed to support the delivery of innovative healthcare solutions, reinforcing Novartis's commitment to improving patient lives on a national level.

Prateek Gaur, the Chief of Staff, Medical Affairs at Novartis, provides critical strategic support and operational oversight to the Medical Affairs division. This role involves coordinating key initiatives that advance the company's research and development of innovative treatments across various therapeutic areas. Gaur works closely with medical leadership to ensure the effective execution of clinical strategies and the dissemination of scientific information. The position requires a deep understanding of pharmaceutical development and a commitment to improving patient outcomes through evidence-based medicine. Prateek Gaur facilitates communication and collaboration between different departments, ensuring seamless integration of medical insights into product development and lifecycle management. This executive's responsibilities include managing projects, optimizing resource allocation, and supporting the strategic direction of medical affairs to address unmet medical needs globally. The focus is on driving scientific progress and enhancing the company's reputation for medical excellence.

Osamu Ida, the Regional Chief Marketing Officer, Head Patient Safety Quality Assurance , Ps Quality Assurance Regions & Countries, Gdd Quality Assurance (Region Japan) at Novartis, leads critical marketing strategies and oversees patient safety and quality assurance functions within Japan. This multifaceted role involves developing and executing innovative marketing campaigns to promote Novartis's pharmaceutical products and healthcare solutions. Ida also ensures rigorous adherence to patient safety protocols and quality standards across all operations in the region, aligning with global GDD Quality Assurance guidelines. The position demands a comprehensive understanding of the Japanese healthcare market, regulatory requirements, and patient needs. Osamu Ida's leadership is pivotal in driving market growth while upholding the highest standards of product quality and patient well-being. This executive's dual focus on commercial success and uncompromising safety underscores Novartis's commitment to delivering trusted and effective treatments to patients in Japan.

Soukaïna Mouallif, the Customer Engagement Chief of Staff (US) at Novartis, spearheads strategic initiatives to enhance customer engagement across the United States market. This role involves optimizing interactions with healthcare professionals, patients, and other stakeholders to foster stronger relationships and improve access to innovative treatments. Mouallif works closely with commercial and medical teams to develop and implement customer-centric strategies that align with Novartis's mission of reimagining medicine. The position requires a keen understanding of the US healthcare landscape and a commitment to driving patient-centric solutions. Soukaïna Mouallif facilitates cross-functional collaboration to ensure seamless execution of engagement programs and supports the development of digital tools and platforms that enhance customer experience. This executive's focus is on building lasting partnerships and ensuring that Novartis's solutions effectively meet the evolving needs of the US market, thereby contributing to improved patient outcomes.

Daniela Castaneda, the Immunology Director, Commercial Operations & Chief of Staff at Novartis, drives strategic commercial initiatives within the Immunology therapeutic area. This leadership position involves overseeing the operational execution of marketing and sales strategies designed to expand patient access to groundbreaking immunology treatments. Castaneda works closely with cross-functional teams to ensure seamless integration of commercial efforts with research and development objectives. The role requires a profound understanding of the immunology landscape, market dynamics, and patient needs. Daniela Castaneda facilitates strategic planning and resource management to maximize the impact of Novartis's immunology portfolio. This executive's focus is on translating scientific innovation into tangible patient benefits, reinforcing Novartis's commitment to addressing complex autoimmune and inflammatory conditions through advanced pharmaceutical solutions.

Amer Al Subaie, the Chief People Officer Head of Administration at Novartis, leads human resources strategy and oversees administrative functions critical to the company's global operations. This executive role focuses on cultivating a high-performing organizational culture, attracting and retaining top talent, and ensuring a supportive work environment. Al Subaie's responsibilities include developing and implementing comprehensive HR policies, managing employee relations, and driving initiatives that promote diversity, equity, and inclusion. The position requires a strategic approach to talent management and organizational development within the pharmaceutical industry. Amer Al Subaie ensures that administrative processes are streamlined and efficient, enabling Novartis to focus on its core mission of developing innovative medicines. This executive's leadership is instrumental in building a motivated and engaged workforce, essential for achieving the company's ambitious goals in scientific research and patient care worldwide.